{"title":"Unbound bilirubin-based management of neonatal hyperbilirubinemia: The Japanese experience and global adaptation.","authors":"Sota Iwatani, Ichiro Morioka, Hajime Nakamura","doi":"10.1016/j.semperi.2026.152294","DOIUrl":"https://doi.org/10.1016/j.semperi.2026.152294","url":null,"abstract":"<p><p>Neonatal hyperbilirubinemia is common, but bilirubin-induced neurologic dysfunction (BIND) remains an important cause of preventable morbidity, particularly in preterm infants. Japan has developed a distinctive approach centered on unbound bilirubin (UB), the biologically active fraction. Nakamura and colleagues pioneered neonatal UB measurement in the 1970s and incorporated UB measurements into the Kobe University (Nakamura) criteria in 1991. With improved survival of extremely preterm infants, bilirubin encephalopathy was still observed despite modest total serum bilirubin (TSB) levels that persisted beyond the first postnatal week. These observations led Morioka to revise the criteria in 2017, incorporating gestational age (GA), corrected GA, UB levels, and staged treatment throughout the prolonged neonatal course. Clinical experience suggests that this approach may reduce phototherapy exposure without increasing UB levels or exchange transfusion, although multicenter evidence with long-term neurodevelopmental outcomes remains limited. The Japanese experience emphasizes longitudinal monitoring and bilirubin-albumin binding characteristics beyond TSB levels alone. Transcutaneous bilirubin, albumin, and bilirubin-albumin molar ratio may facilitate screening, while emerging fluorescence-based methods may improve UB accessibility. UB measurement should be viewed as a framework for individualized risk assessment, with principles adaptable to diverse populations and clinical settings.</p>","PeriodicalId":21761,"journal":{"name":"Seminars in perinatology","volume":" ","pages":"152294"},"PeriodicalIF":3.2,"publicationDate":"2026-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148888645","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Seminars in perinatologyPub Date : 2026-09-01Epub Date: 2026-04-02DOI: 10.1016/j.semperi.2026.152227
Xuxin Chen, Richard A. Polin
{"title":"The role of physical examination in the identification of neonates with early-onset sepsis","authors":"Xuxin Chen, Richard A. Polin","doi":"10.1016/j.semperi.2026.152227","DOIUrl":"10.1016/j.semperi.2026.152227","url":null,"abstract":"<div><div>Early-onset sepsis (EOS), defined as infection within the first 72 h of life, remains a major concern in neonatal care. Historically, many late preterm (≥34 weeks) and term infants at risk for infection (e.g., exposure to maternal intraamniotic infection [chorioamnionitis], or prolonged rupture of membranes) received empiric antibiotics after birth. However, most of these infants were ultimately without infection, leading to unnecessary antibiotic exposure, NICU admissions, and disruptions in maternal-infant bonding. Recent evidence and guidelines support serial physical examinations (SPEs) or structured clinical observation as a safe and effective alternative to routine empiric antibiotics in well-appearing infants. The purpose of this review is to describe the evidence supporting SPEs as a safe and effective strategy for managing well-appearing late preterm and term infants at risk for early onset sepsis.</div></div>","PeriodicalId":21761,"journal":{"name":"Seminars in perinatology","volume":"50 6","pages":"Article 152227"},"PeriodicalIF":3.2,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147616477","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Seminars in perinatologyPub Date : 2026-09-01Epub Date: 2026-07-14DOI: 10.1016/j.semperi.2026.152280
Jana Shaw
{"title":"The uprise of congenital syphilis in the United States: a preventable failure of perinatal systems","authors":"Jana Shaw","doi":"10.1016/j.semperi.2026.152280","DOIUrl":"10.1016/j.semperi.2026.152280","url":null,"abstract":"<div><div>Congenital syphilis is a preventable infection caused by vertical transmission of <em>Treponema pallidum</em> during pregnancy. Despite effective screening and curative treatment, rates in the United States have risen sharply over the past decade, paralleling increasing syphilis rates among reproductive-aged adults. This resurgence reflects systemic gaps in healthcare access, public health infrastructure, and social support systems. Adverse outcomes include stillbirth, neonatal death, prematurity, and long-term neurologic, skeletal, and auditory complications.</div><div>This review summarizes current U.S. epidemiologic trends and examines multifactorial drivers of rising congenital syphilis, including inadequate or absent prenatal care, missed or delayed screening, reinfection during pregnancy, and social determinants such as poverty, substance use, and healthcare inequities. System-level challenges such as inconsistent screening practices, treatment delays, and under-resourced public health programs-further sustain transmission.</div><div>Evidence-based prevention strategies include universal early pregnancy screening, repeat testing for high-risk patients, prompt penicillin treatment, strengthened partner services, and expanded prenatal care access. Policy initiatives and community-based outreach are essential to address structural disparities and improve care engagement.</div><div>Congenital syphilis is a sentinel marker of healthcare system performance. Coordinated clinical, public health, and policy efforts are urgently needed to reverse current trends and achieve elimination in the United States.</div></div>","PeriodicalId":21761,"journal":{"name":"Seminars in perinatology","volume":"50 6","pages":"Article 152280"},"PeriodicalIF":3.2,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148449434","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Seminars in perinatologyPub Date : 2026-09-01Epub Date: 2026-07-29DOI: 10.1016/j.semperi.2026.152281
Lakshmi Srinivasan, Paul J. Planet
{"title":"Advancing the science of Staphylococcus aureus infection prevention in the neonatal intensive care unit","authors":"Lakshmi Srinivasan, Paul J. Planet","doi":"10.1016/j.semperi.2026.152281","DOIUrl":"10.1016/j.semperi.2026.152281","url":null,"abstract":"<div><div>Despite advances in infection prevention, infections due to <em>Staphylococcus</em> aureus continue to be an important cause of morbidity and mortality in NICUs. Whole genome sequencing (WGS) using advanced analytic approaches for defining transmission have shed new insights into transmission and persistence patterns in the NICU. WGS has also helped uncover important associations between transmission, persistence, and the risk of invasive infections. Current infection prevention strategies rely on hand hygiene compliance and surveillance and decolonization of patients positive for <em>S. aureus</em>. Parent decolonization may also play a role in decreasing parent-child transmission. In the future, precision surveillance of high-risk strains and targeted infection prevention efforts to decrease bacterial burden of those specific strains may provide a more effective and efficient approach to decreasing risk of invasive infections.</div></div>","PeriodicalId":21761,"journal":{"name":"Seminars in perinatology","volume":"50 6","pages":"Article 152281"},"PeriodicalIF":3.2,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148621123","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Seminars in perinatologyPub Date : 2026-09-01Epub Date: 2026-06-09DOI: 10.1016/j.semperi.2026.152257
Dhanya Dharmapalan, Nupur Sinha
{"title":"MDRO infections in the NICU- The international perspective","authors":"Dhanya Dharmapalan, Nupur Sinha","doi":"10.1016/j.semperi.2026.152257","DOIUrl":"10.1016/j.semperi.2026.152257","url":null,"abstract":"<div><div>Neonatal sepsis due to Multidrug resistant organisms (MDRO) is a huge burden in resource limited settings of South Asia and Africa. The epidemiology, risk factors, diagnostic and management challenges differ significantly in the resource limited settings as compared to the resource rich settings, particularly for Gram-negative MDROs. Lack of diagnostic facilities, limited access to therapeutic options, inability to effectively control horizontal transmission in the neonatal care units due to limited resources are major hurdles in combating MDRO infections in neonates. The low sensitivity of gold standard blood cultures and paucity of pharmacokinetic data in neonates make the overall picture grim.</div><div>Research studies over the past decade have identified high resistance to the first line and second line treatment regimens recommended by the World Health Organisation (WHO). The progress towards finding customised solutions has been slow. Novel betalactam-betalactamase antibiotics are effective against several MDROs but are expensive. Repurposed antibiotics like fosfomycin and flomoxef hold promise as therapeutic options.</div><div>The continued critical gaps need to be urgently addressed as national priorities and through international support and cooperation.</div></div>","PeriodicalId":21761,"journal":{"name":"Seminars in perinatology","volume":"50 6","pages":"Article 152257"},"PeriodicalIF":3.2,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148212524","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Seminars in perinatologyPub Date : 2026-09-01Epub Date: 2026-05-13DOI: 10.1016/j.semperi.2026.152248
Noa Fleiss, Matthew J. Bizzarro
{"title":"Neonatal early-onset sepsis: A changing paradigm of pathogens and high-risk cohorts","authors":"Noa Fleiss, Matthew J. Bizzarro","doi":"10.1016/j.semperi.2026.152248","DOIUrl":"10.1016/j.semperi.2026.152248","url":null,"abstract":"<div><div>The causative pathogens of neonatal early-onset sepsis (EOS) have changed over time with a shift towards gram-negative organisms. This change is likely multifactorial and due in part to a high prevalence of maternal intrapartum antibiotic exposure leading to alterations in rectovaginal colonization with antibiotic-resistant organisms and subsequent neonatal colonization and infection. As a result, neonatal EOS secondary to gram-negative pathogens, particularly <em>Escherichia coli (E. coli),</em> is becoming more aggressive, resistant and difficult to treat, and not exclusive to very low birth weight infants with more EOS emerging in late preterm and term infants. Therefore, a heightened awareness regarding the dangers of resistant bacterial infections in neonates is critical, as well as a reevaluation of current maternal and neonatal surveillance and prevention efforts.</div></div>","PeriodicalId":21761,"journal":{"name":"Seminars in perinatology","volume":"50 6","pages":"Article 152248"},"PeriodicalIF":3.2,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147933310","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Seminars in perinatologyPub Date : 2026-09-01Epub Date: 2026-07-02DOI: 10.1016/j.semperi.2026.152278
Karen Ravin, Terri Stillwell
{"title":"Congenital cytomegalovirus: Screening strategies and diagnostic challenges","authors":"Karen Ravin, Terri Stillwell","doi":"10.1016/j.semperi.2026.152278","DOIUrl":"10.1016/j.semperi.2026.152278","url":null,"abstract":"<div><div>Congenital cytomegalovirus (cCMV) infection is the most common congenital infection worldwide and a leading cause of sensorineural hearing loss (SNHL). Most newborns with cCMV will be asymptomatic at birth; however, a subset will go on to develop disease, including SNHL and neurodevelopmental problems, later in life. Given this, advocacy for newborn cCMV screening is growing. Targeted versus universal screening remains a hotly debated topic. This review will assess current diagnostic and screening modalities and explore unanswered questions.</div></div>","PeriodicalId":21761,"journal":{"name":"Seminars in perinatology","volume":"50 6","pages":"Article 152278"},"PeriodicalIF":3.2,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148369733","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Seminars in perinatologyPub Date : 2026-09-01Epub Date: 2026-08-06DOI: 10.1016/j.semperi.2026.152291
Noa Fleiss, Thomas S. Murray
{"title":"Seminars in perinatology preface: Neonatal infectious diseases: shifts, challenges and strategies","authors":"Noa Fleiss, Thomas S. Murray","doi":"10.1016/j.semperi.2026.152291","DOIUrl":"10.1016/j.semperi.2026.152291","url":null,"abstract":"","PeriodicalId":21761,"journal":{"name":"Seminars in perinatology","volume":"50 6","pages":"Article 152291"},"PeriodicalIF":3.2,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148685681","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Seminars in perinatologyPub Date : 2026-09-01Epub Date: 2026-05-16DOI: 10.1016/j.semperi.2026.152249
Nathan L’Etoile, Thomas S. Murray
{"title":"Candida auris in the neonatal intensive care unit","authors":"Nathan L’Etoile, Thomas S. Murray","doi":"10.1016/j.semperi.2026.152249","DOIUrl":"10.1016/j.semperi.2026.152249","url":null,"abstract":"<div><div><em>Candida (a.k.a.Candidozyma) auris</em> is a healthcare-associated yeast that has attracted attention due to its increased antimicrobial resistance and ability to spread rapidly within the healthcare environment. Infants admitted to the neonatal intensive care unit (NICU) have risk factors such as broad spectrum antibiotic exposure, prematurity and congenital heart disease that predispose them to serious infection with <em>C. auris.</em> Consequently, there have been global reports of <em>C. auris</em> outbreaks in NICUs associated with high mortality. The clinical presentation of late onset sepsis with <em>C. auris</em> is indistinguishable from other etiologies. Echinocandins remain the empiric therapy of choice along with amphotericin B in select cases. Identification of an invasive case of <em>C. auris</em> in the NICU requires implementation of infection prevention and control measures including contact precautions, enhanced environmental cleaning and disinfection, and the screening of other infants for colonization. Areas where research is needed include optimal antifungal therapy for treatment and prophylaxis, the ideal body sites to screen for colonization, the length of time infants remain colonized with <em>C. auris,</em> and the risk of infant colonization from breast feeding and skin-to-skin practices with colonized or infected caregivers. Continued reporting of the clinical experience of NICUs that experience <em>C. auris</em> is essential to expand our knowledge and to protect neonates and infants from this evolving pathogen.</div></div>","PeriodicalId":21761,"journal":{"name":"Seminars in perinatology","volume":"50 6","pages":"Article 152249"},"PeriodicalIF":3.2,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147960263","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Cochlear implantation for sensorineural hearing loss caused by neonatal hyperbilirubinemia.","authors":"Melodyanne Y Cheng, John S Oghalai","doi":"10.1016/j.semperi.2026.152293","DOIUrl":"10.1016/j.semperi.2026.152293","url":null,"abstract":"<p><strong>Background: </strong>Hyperbilirubinemia is a leading cause of sensorineural hearing loss (SNHL) and auditory neuropathy spectrum disorder (ANSD) in neonates. This review synthesizes current evidence to describe key aspects of cochlear implantation (CI) in neonates with hyperbilirubinemia.</p><p><strong>Objective: </strong>To educate a wide audience on the pathophysiology, audiometric challenges, hearing aid trial considerations, optimal timing, and expected outcomes of CI in neonates with bilirubin-induced hearing loss.</p><p><strong>Methods: </strong>A comprehensive review was conducted on PubMed and Cochrane databases to explore current clinical practice guidance for evaluating neonates with hyperbilirubinemia for CI.</p><p><strong>Results: </strong>Bilirubin has neurotoxic effects on the auditory pathway in neonates, making it challenging to have strict audiometric criteria for CI. Hearing trials serve the dual purpose of diagnosis and therapy for infants with hearing loss and can identify strong candidates for CI or, conversely, exclude children who may not benefit from CI. Optimal timing of CI balances diagnostic certainty with earlier intervention. Provider counseling is crucial in preparing families for expected outcomes after CI, which are generally favorable, but can vary among infants depending on factors such as interdisciplinary care coordination.</p><p><strong>Conclusion: </strong>Audiologic monitoring, careful CI decision-making, and realistic outcome counseling optimize candidate selection and care for neonates with bilirubin-induced hearing loss.</p>","PeriodicalId":21761,"journal":{"name":"Seminars in perinatology","volume":" ","pages":"152293"},"PeriodicalIF":3.2,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13564048/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148875038","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}